Claims for Patent: 10,226,595

Summary for Patent: 10,226,595

Title:	Spring cannulae
Abstract:	Disclosed herein are embodiments of spring cannulae, including one or more holes in the sidewall of the cannula. Some disclosed cannulae include a wire, helically wound to form coils, and at least one hole in the cannula that interrupts one or more of the coils. Some embodiments further include a fused region of the coils through which the hole passes. Some embodiments include a ring attached to ends of the interrupted coils, where the hole is surrounded by the ring. Some embodiments include a sheath that is attached to a radial surface of the interrupted coils, where the hole passes radially though the sheath. Some embodiments include an elongated coil with a hole passing between the elongated coil and an adjacent coil. Further embodiments disclose cannulae that include a wire helically wound to form coils, and an insert having a porous section with at least one hole.
Inventor(s):	Manouchehr A. Miraki, Bryan Janish, Raymond J. McManus, Brent K. Hoffman
Assignee:	Edwards Lifesciences Corp
Application Number:	US15/107,404

Details for Patent 10,226,595

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Csl Behring Gmbh	HAEGARDA	c1 esterase inhibitor subcutaneous (human)	For Injection	125606	June 22, 2017		2035-06-16

International Patent Family for US Patent 10,226,595

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015195646
United States of America	2022062582
United States of America	2019201661
United States of America	2017021127
United States of America	11806483